Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites

Oncogene volume 19, pages 1379–1385 (2000)Cite this article

Abstract

The c-fos enhancer can be activated by many signaling pathways through distinct elements of the enhancer. The enhancer contains at its core the serum response element (SRE) that binds serum response factor (SRF). On the 5′ side of the SRE is a site for p62TCF which binds only when SRF is bound as well. p62TCF is encoded by three ets-related genes, Elk-1, SAP1 and SAP2. Each of these factors contain a transcriptional activation domain that is activated by phosphorylation by MAP kinases. On the 3′ side of the SRE is the ‘c-fos AP1 site’ (FAP1) whose role has been less clear. We find here that the FAP1 site contributes strongly to phorbol ester (TPA) and Erk MAP kinase activation of the c-fos enhancer and that both the p62TCF and FAP1 sites are required for effective activation of the enhancer. We further find that the FAP1 site binds ATF1 and CREB from HeLa nuclear extracts and that the phosphorylation of these factors is induced by TPA. ATF1 and CREB can be phosphorylated by Rsk2 which is a protein kinase directly activated by Erk MAP kinases. These results suggest a signaling pathway in which Erk MAP kinase activates the c-fos enhancer by direct phosphorylation of p62TCF and by activation of Rsk related kinases that phosphorylate ATF1 and CREB.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Attar RM and Gilman MZ . 1992 Mol Cell Biol 12: 2432–2443

  • Berkowitz LA, Riabowol KT and Gilman MZ . 1989 Mol Cell Biol 9: 4272–4281

  • Bruder JT, Heidecker G and Rapp UR . 1992 Genes Dev 6: 545–556

  • Chen X and Prywes R . 1999 Mol Cell Biol 19: 4695–4702

  • Clarke N, Arenzana N, Hai T, Minden A and Prywes R . 1998 Mol Cell Biol 18: 1065–1073

  • De Cesare D, Fimia GM and Sassone-Corsi P . 1999 Trends Biochem Sci 24: 281–285

  • De Cesare D, Jacquot S, Hanauer A and Sassone-Corsi P . 1998 Proc Natl Acad Sci USA 95: 12202–12207

  • Deak M, Clifton AD, Lucocq LM and Alessi DR . 1998 EMBO J 17: 4426–4441

  • Fisch TM, Prywes R and Roeder RG . 1987 Mol Cell Biol 7: 3490–3502

  • Fisch TM, Prywes R, Simon MC and Roeder RG . 1989 Genes Dev 3: 198–211

  • Fu XY and Zhang JJ . 1993 Cell 74: 1135–1145

  • Gille H, Sharrocks AD and Shaw PE . 1992 Nature 358: 414–417

  • Ginty DD, Bonni A and Greenberg ME . 1994 Cell 77: 713–725

  • Gonzalez GA and Montminy MR . 1989 Cell 59: 675–680

  • Graham R and Gilman M . 1991 Science 251: 189–192

  • Grueneberg DA, Henry RW, Brauer A, Novina CD, Cheriyath V, Roy AL and Gilman M . 1997 Genes Dev 11: 2482–2493

  • Gualberto A, LePage D, Pons G, Mader SL, Park K, Atchison ML and Walsh K . 1992 Mol Cell Biol 12: 4209–4214

  • Hill CS, Wynne J and Treisman R . 1995 Cell 81: 1159–1170

  • Iordanov M, Bender K, Ade T, Schmid W, Sachsenmaier C, Engel K, Gaestel M, Rahmsdorf HJ and Herrlich P . 1997 EMBO J 16: 1009–1022

  • Johansen FE and Prywes R . 1995 Biochim Biophys Acta 1242: 1–10

  • Kim DW, Cheriyath V, Roy AL and Cochran BH . 1998 Mol Cell Biol 18: 3310–3320

  • Liu F, Thompson MA, Wagner S, Greenberg ME and Green MR . 1993 J Biol Chem 268: 6714–6720

  • Marais R, Wynne J and Treisman R . 1993 Cell 73: 381–393

  • Matthews RP, Guthrie CR, Wailes LM, Zhao X, Means AR and McKnight GS . 1994 Mol Cell Biol 14: 6107–6116

  • Metz R and Ziff E . 1991 Oncogene 6: 2165–2178

  • Miranti CK, Ginty DD, Huang G, Chatila T and Greenberg ME . 1995 Mol Cell Biol 15: 3672–3684

  • Mitchell PJ and Tjian R . 1989 Science 245: 371–378

  • Montminy M . 1997 Annu Rev Biochem 66: 807–822

  • Pierrat B, Correia JS, Mary JL, Tomas-Zuber M and Lesslauer W . 1998 J Biol Chem 273: 29661–29671

  • Prywes R and Roeder RG . 1986 Cell 47: 777–784

  • Qiu RG, Chen J, McCormick F and Symons M . 1995 Proc Natl Acad Sci USA 92: 11781–11785

  • Rehfuss RP, Walton KM, Loriaux MM and Goodman RH . 1991 J Biol Chem 266: 18431–18434

  • Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI and Curran T . 1995 Neuron 14: 241–252

  • Sadowski HB, Shuai K, Darnell Jr JE and Gilman MZ . 1993 Science 261: 1739–1744

  • Sambrook J, Fritsch E and Maniatis T . 1989 Molecular cloning a laboratory manual Second edn Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

    Google Scholar 

  • Sassone-Corsi P, Visvader J, Ferland L, Mellon PL and Verma IM . 1988 Genes Dev 2: 1529–1538

  • Shaw PE, Schroter H and Nordheim A . 1989 Cell 56: 563–572

  • Sheng M, McFadden G and Greenberg ME . 1990 Neuron 4: 571–582

  • Siegfried Z and Ziff EB . 1989 Oncogene 4: 3–11

  • Sotiropoulos A, Gineitis D, Copeland J and Treisman R . 1999 Cell 98: 159–169

  • Tan Y, Rouse J, Zhang A, Cariati S, Cohen P and Comb MJ . 1996 EMBO J 15: 4629–4642

  • Treisman R . 1992 Trends Biochem Sci 17: 423–426

  • Treisman R . 1994 Curr Opin Genet Dev 4: 96–101

  • Treisman R . 1996 Curr Opin Cell Biol 8: 205–215

  • Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P and Hanauer A . 1996 Nature 384: 567–570

  • Wagner BJ, Hayes TE, Hoban CJ and Cochran BH . 1990 EMBO J 9: 4477–4484

  • Wang Y, Falasca M, Schlessinger J, Malstrom S, Tsichlis P, Settleman J, Hu W, Lim B and Prywes R . 1998 Cell Growth Differ 9: 513–522

  • Whitmarsh AJ, Shore P, Sharrocks AD and Davis RJ . 1995 Science 269: 403–407

  • Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD and Davis RJ . 1997 Mol Cell Biol 17: 2360–2371

  • Xing J, Ginty DD and Greenberg ME . 1996 Science 273: 959–963

  • Xing J, Kornhauser JM, Xia Z, Thiele EA and Greenberg ME . 1998 Mol Cell Biol 18: 1946–1955

  • Young ID . 1988 J Med Genet 25: 344–348

  • Zhu C, Johansen FE and Prywes R . 1997 Mol Cell Biol 17: 4957–4966

Download references

Acknowledgements

We thank Dr Michael Greenberg for RSK and CREB plasmids and anti-CREB sera and Dr Tsonwin Hai for anti-ATF family sera. This work was supported by grant CA 50329 from the National Cancer Institute and the National Institutes of Health to R Prywes.

Author information

Authors and Affiliations

  1. Department of Biological Sciences, Columbia University, New York, 10027, NY, USA

    Yan Wang & Ron Prywes

Authors
  1. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ron Prywes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Prywes, R. Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 19, 1379–1385 (2000). https://doi.org/10.1038/sj.onc.1203443

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203443

Keywords

This article is cited by

Search

Advanced search

Quick links